Skip to main content
Top
Published in: BMC Nephrology 1/2022

Open Access 01-12-2022 | Coronary Heart Disease | Research article

Association of plasma neutrophil gelatinase-associated lipocalin and thoracic aorta calcification in maintenance hemodialysis patients with and without diabetes

Authors: Kai Wei, Gesheng Song, Linhe Xi, Juan Chen, Chuancai Sun, Ping Chen, Yong Wei, Li Wang, Xianglei Kong, Yang Li, Dongmei Xu, Xiaoyan Jia

Published in: BMC Nephrology | Issue 1/2022

Login to get access

Abstract

Background

Neutrophil gelatinase-associated lipocalin (NGAL) is not only a bone-derived factor involved in metabolism, but also a biomarker of kidney disease and cardiovascular pathophysiology. We conducted this cross-sectional observational study to explore relationships between plasma NGAL and thoracic aorta calcification (TAC) in maintenance hemodialysis (MHD) patients with and without diabetes.

Methods

Plasma NGAL was measured by ELISA, TAC was evaluated via computed tomography scan using a 3D quantification method or chest radiography aortic arch calcification score. Spearman correlation, Logistic regression and Partial correlation analysis were used to describe the correlations between NGAL and TAC.

Results

Plasma NGAL levels were lower in MHD patients with diabetes compared to those without diabetes (49.33(42.37, 55.48) vs 56.78(44.37, 674.13) ng/mL, P = 0.026). In MHD patients without diabetes, lg (NGAL) was positively correlated with ARC value(R = 0.612, P = 0.003) analyzed by Spearman correlation; for partial correlation analysis, lg (NGAL) was positively correlated with ARC value, after adjusting for age and sex (R = 0.550, P = 0.015), adjusting for age, sex and CHD (R = 0.565, P = 0.015), adjusting for age, sex, CHD and Alb (R = 0.536, P = 0.027), or adjusting for age, sex, CHD, Alb, and dialyzer membrane (polysulfone) (R = 0.590, P = 0.016); however, when adjusting for age, sex, CHD, Alb and Ca, the correlation between lg (NGAL) and ARC value disappeared. Positive correlation were found between NGAL and Ca (R = 0.644, P < 0.001), Ca and ACR (R = 0.534, P = 0.013) in Spearman coefficient analysis.

Conclusion

There were positive correlations among plasma NGAL, serum Ca and ARC in MHD patients without diabetes; which suggests that NGAL is possibly a participant in cardiovascular calcification, in non-diabetic MHD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Asimakopoulou A, Borkham-Kamphorst E, Tacke F, Weiskirchen R. Lipocalin-2 (NGAL/LCN2), a "help-me" signal in organ inflammation. Hepatology. 2016;63(2):669–71.CrossRef Asimakopoulou A, Borkham-Kamphorst E, Tacke F, Weiskirchen R. Lipocalin-2 (NGAL/LCN2), a "help-me" signal in organ inflammation. Hepatology. 2016;63(2):669–71.CrossRef
2.
go back to reference Buonafine M, Martinez-Martinez E, Jaisser F. More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases. Clin Sci (Lond). 2018;132(9):909–23.CrossRef Buonafine M, Martinez-Martinez E, Jaisser F. More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases. Clin Sci (Lond). 2018;132(9):909–23.CrossRef
3.
go back to reference Abella V, Scotece M, Conde J, Gómez R, Lois A, Pino J, et al. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers. 2015;20(8):565–71.CrossRef Abella V, Scotece M, Conde J, Gómez R, Lois A, Pino J, et al. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers. 2015;20(8):565–71.CrossRef
4.
go back to reference Gouweleeuw L, Naudé PJ, Rots M, DeJongste MJ, Eisel UL, Schoemaker RG. The role of neutrophil gelatinase associated lipocalin (NGAL) as biological constituent linking depression and cardiovascular disease. Brain Behav Immun. 2015;46:23–32.CrossRef Gouweleeuw L, Naudé PJ, Rots M, DeJongste MJ, Eisel UL, Schoemaker RG. The role of neutrophil gelatinase associated lipocalin (NGAL) as biological constituent linking depression and cardiovascular disease. Brain Behav Immun. 2015;46:23–32.CrossRef
5.
go back to reference Mosialou I, Shikhel S, Liu JM, Maurizi A, Luo N, He Z, et al. MC4R-dependent suppression of appetite by bone-derived lipocalin 2. Nature. 2017;543(7645):385–90.CrossRef Mosialou I, Shikhel S, Liu JM, Maurizi A, Luo N, He Z, et al. MC4R-dependent suppression of appetite by bone-derived lipocalin 2. Nature. 2017;543(7645):385–90.CrossRef
6.
go back to reference Luo Y, Ma X, Pan X, Xu Y, Xiong Q, Xiao Y, et al. Serum lipocalin-2 levels are positively associated with not only total body fat but also visceral fat area in Chinese men. Medicine (Baltimore). 2016;95(30):e4039.CrossRef Luo Y, Ma X, Pan X, Xu Y, Xiong Q, Xiao Y, et al. Serum lipocalin-2 levels are positively associated with not only total body fat but also visceral fat area in Chinese men. Medicine (Baltimore). 2016;95(30):e4039.CrossRef
7.
go back to reference Jaberi SA, Cohen A, D'Souza C, Abdulrazzaq YM, Ojha S, Bastaki S, et al. Lipocalin-2: structure, function, distribution and role in metabolic disorders. Biomed Pharmacother. 2021;142:112002.CrossRef Jaberi SA, Cohen A, D'Souza C, Abdulrazzaq YM, Ojha S, Bastaki S, et al. Lipocalin-2: structure, function, distribution and role in metabolic disorders. Biomed Pharmacother. 2021;142:112002.CrossRef
8.
go back to reference Bedouhène S, Dang PM, Hurtado-Nedelec M, El-Benna J. Neutrophil degranulation of Azurophil and specific granules. Methods Mol Biol. 2020;2087:215–22.CrossRef Bedouhène S, Dang PM, Hurtado-Nedelec M, El-Benna J. Neutrophil degranulation of Azurophil and specific granules. Methods Mol Biol. 2020;2087:215–22.CrossRef
9.
go back to reference Lekva T, Gullestad L, Broch K, Aukrust P, Andreassen AK, Ueland T. Distinct patterns of soluble leukocyte activation markers are associated with etiology and outcomes in precapillary pulmonary hypertension. Sci Rep. 2020;10(1):18540.CrossRef Lekva T, Gullestad L, Broch K, Aukrust P, Andreassen AK, Ueland T. Distinct patterns of soluble leukocyte activation markers are associated with etiology and outcomes in precapillary pulmonary hypertension. Sci Rep. 2020;10(1):18540.CrossRef
10.
go back to reference Araos P, Prado C, Lozano M, Figueroa S, Espinoza A, Berger T, et al. Dendritic cells are crucial for cardiovascular remodeling and modulate neutrophil gelatinase-associated lipocalin expression upon mineralocorticoid receptor activation. J Hypertens. 2019;37(7):1482–92.CrossRef Araos P, Prado C, Lozano M, Figueroa S, Espinoza A, Berger T, et al. Dendritic cells are crucial for cardiovascular remodeling and modulate neutrophil gelatinase-associated lipocalin expression upon mineralocorticoid receptor activation. J Hypertens. 2019;37(7):1482–92.CrossRef
11.
go back to reference Meyers K, López M, Ho J, Wills S, Rayalam S, Taval S. Lipocalin-2 deficiency may predispose to the progression of spontaneous age-related adiposity in mice. Sci Rep. 2020;10(1):14589.CrossRef Meyers K, López M, Ho J, Wills S, Rayalam S, Taval S. Lipocalin-2 deficiency may predispose to the progression of spontaneous age-related adiposity in mice. Sci Rep. 2020;10(1):14589.CrossRef
12.
go back to reference Marques FZ, Prestes PR, Byars SG, Ritchie SC, Würtz P, Patel SK, et al. Experimental and human evidence for Lipocalin-2 (neutrophil gelatinase-associated Lipocalin [NGAL]) in the development of cardiac hypertrophy and heart failure. J Am Heart Assoc. 2017;6(6):e005971.CrossRef Marques FZ, Prestes PR, Byars SG, Ritchie SC, Würtz P, Patel SK, et al. Experimental and human evidence for Lipocalin-2 (neutrophil gelatinase-associated Lipocalin [NGAL]) in the development of cardiac hypertrophy and heart failure. J Am Heart Assoc. 2017;6(6):e005971.CrossRef
13.
go back to reference Olson B, Zhu X, Norgard MA, Diba P, Levasseur PR, Buenafe AC, et al. Chronic cerebral lipocalin 2 exposure elicits hippocampal neuronal dysfunction and cognitive impairment. Brain Behav Immun. 2021;S0889-1591(21):00266–X. Olson B, Zhu X, Norgard MA, Diba P, Levasseur PR, Buenafe AC, et al. Chronic cerebral lipocalin 2 exposure elicits hippocampal neuronal dysfunction and cognitive impairment. Brain Behav Immun. 2021;S0889-1591(21):00266–X.
14.
go back to reference Krizanac M, Mass Sanchez PB, Weiskirchen R, Asimakopoulos A. A scoping review on Lipocalin-2 and its role in non-alcoholic steatohepatitis and hepatocellular carcinoma. Int J Mol Sci. 2021;22(6):2865.CrossRef Krizanac M, Mass Sanchez PB, Weiskirchen R, Asimakopoulos A. A scoping review on Lipocalin-2 and its role in non-alcoholic steatohepatitis and hepatocellular carcinoma. Int J Mol Sci. 2021;22(6):2865.CrossRef
15.
go back to reference Malyszko J, Malyszko JS, Koc-Zorawska E, Kozminski P, Mysliwiec M. Neutrophil gelatinase-associated lipocalin in dialyzed patients is related to residual renal function, type of renal replacement therapy and inflammation. Kidney Blood Press Res. 2009;32(6):464–9.CrossRef Malyszko J, Malyszko JS, Koc-Zorawska E, Kozminski P, Mysliwiec M. Neutrophil gelatinase-associated lipocalin in dialyzed patients is related to residual renal function, type of renal replacement therapy and inflammation. Kidney Blood Press Res. 2009;32(6):464–9.CrossRef
16.
go back to reference Song X, Cai D, Zhang B. Clinical values of serum NGAL combined with NT-proBNP in the early prognosis of type 1 cardiorenal syndrome. Am J Transl Res. 2021;13(4):3363–8.PubMedPubMedCentral Song X, Cai D, Zhang B. Clinical values of serum NGAL combined with NT-proBNP in the early prognosis of type 1 cardiorenal syndrome. Am J Transl Res. 2021;13(4):3363–8.PubMedPubMedCentral
17.
go back to reference Shang W, Wang Z. The update of NGAL in acute kidney injury. Curr Protein Pept Sci. 2017;18(12):1211–7.CrossRef Shang W, Wang Z. The update of NGAL in acute kidney injury. Curr Protein Pept Sci. 2017;18(12):1211–7.CrossRef
18.
go back to reference Lin X, Onda DA, Yang CH, Lewis JR, Levinger I, Loh K. Roles of bone-derived hormones in type 2 diabetes and cardiovascular pathophysiology. Mol Metab. 2020;40:101040.CrossRef Lin X, Onda DA, Yang CH, Lewis JR, Levinger I, Loh K. Roles of bone-derived hormones in type 2 diabetes and cardiovascular pathophysiology. Mol Metab. 2020;40:101040.CrossRef
20.
go back to reference Rogers MA, Aikawa E. Cardiovascular calcification: artificial intelligence and big data accelerate mechanistic discovery. Nat Rev Cardiol. 2019;16(5):261–74.CrossRef Rogers MA, Aikawa E. Cardiovascular calcification: artificial intelligence and big data accelerate mechanistic discovery. Nat Rev Cardiol. 2019;16(5):261–74.CrossRef
21.
go back to reference Pedrosa JF, Barreto SM, Bittencourt MS, Ribeiro ALP. Anatomical references to evaluate thoracic aorta calcium by computed tomography. Curr Atheroscler Rep. 2019;21(12):51.CrossRef Pedrosa JF, Barreto SM, Bittencourt MS, Ribeiro ALP. Anatomical references to evaluate thoracic aorta calcium by computed tomography. Curr Atheroscler Rep. 2019;21(12):51.CrossRef
22.
go back to reference Fujii H, Kono K, Watanabe K, Goto S, Nishii T, Kono A, et al. Evaluation of aortic calcification using a three-dimensional volume-rendering method in patients with end-stage kidney disease. J Bone Miner Metab. 2021;39(3):439–45.CrossRef Fujii H, Kono K, Watanabe K, Goto S, Nishii T, Kono A, et al. Evaluation of aortic calcification using a three-dimensional volume-rendering method in patients with end-stage kidney disease. J Bone Miner Metab. 2021;39(3):439–45.CrossRef
23.
go back to reference Chong JJH, Prince RL, Thompson PL, Thavapalachandran S, Ooi E, Devine A, et al. Association between plasma neutrophil gelatinase-associated Lipocalin and cardiac disease hospitalizations and deaths in older women. J Am Heart Assoc. 2019;8(1):e011028.CrossRef Chong JJH, Prince RL, Thompson PL, Thavapalachandran S, Ooi E, Devine A, et al. Association between plasma neutrophil gelatinase-associated Lipocalin and cardiac disease hospitalizations and deaths in older women. J Am Heart Assoc. 2019;8(1):e011028.CrossRef
24.
go back to reference Hénaut L, Chillon JM, Kamel S, Massy ZA. Updates on the mechanisms and the Care of Cardiovascular Calcification in chronic kidney disease. Semin Nephrol. 2018;38(3):233–50.CrossRef Hénaut L, Chillon JM, Kamel S, Massy ZA. Updates on the mechanisms and the Care of Cardiovascular Calcification in chronic kidney disease. Semin Nephrol. 2018;38(3):233–50.CrossRef
25.
go back to reference Massy ZA, Drüeke TB. Vascular calcification. Curr Opin Nephrol Hypertens. 2013;22(4):405–12.CrossRef Massy ZA, Drüeke TB. Vascular calcification. Curr Opin Nephrol Hypertens. 2013;22(4):405–12.CrossRef
26.
go back to reference Himmelsbach A, Ciliox C, Goettsch C. Cardiovascular calcification in chronic kidney disease-therapeutic opportunities. Toxins (Basel). 2020;12(3):181.CrossRef Himmelsbach A, Ciliox C, Goettsch C. Cardiovascular calcification in chronic kidney disease-therapeutic opportunities. Toxins (Basel). 2020;12(3):181.CrossRef
27.
go back to reference Nafakhi H, Al-Nafakh HA, Al-Mosawi AA, Al GF. Correlations between aortic root calcification and coronary artery atherosclerotic markers assessed using multidetector computed tomography. Acad Radiol. 2015;22(3):357–62.CrossRef Nafakhi H, Al-Nafakh HA, Al-Mosawi AA, Al GF. Correlations between aortic root calcification and coronary artery atherosclerotic markers assessed using multidetector computed tomography. Acad Radiol. 2015;22(3):357–62.CrossRef
28.
go back to reference Okada H, Tada H, Hayashi K, Kawashima H, Takata T, Sakata K, et al. Aortic root calcification score as an independent factor for predicting major adverse cardiac events in familial hypercholesterolemia. J Atheroscler Thromb. 2018;25(7):634–42.CrossRef Okada H, Tada H, Hayashi K, Kawashima H, Takata T, Sakata K, et al. Aortic root calcification score as an independent factor for predicting major adverse cardiac events in familial hypercholesterolemia. J Atheroscler Thromb. 2018;25(7):634–42.CrossRef
29.
go back to reference Zografos T, Haliassos A, Korovesis S, Giazitzoglou E, Voridis E, Katritsis D. Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease. Am J Cardiol. 2009;104(7):917–20.CrossRef Zografos T, Haliassos A, Korovesis S, Giazitzoglou E, Voridis E, Katritsis D. Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease. Am J Cardiol. 2009;104(7):917–20.CrossRef
30.
go back to reference Wu G, Li H, Fang Q, Jiang S, Zhang L, Zhang J, et al. Elevated circulating lipocalin-2 levels independently predict incident cardiovascular events in men in a population-based cohort. Arterioscler Thromb Vasc Biol. 2014;34(11):2457–64.CrossRef Wu G, Li H, Fang Q, Jiang S, Zhang L, Zhang J, et al. Elevated circulating lipocalin-2 levels independently predict incident cardiovascular events in men in a population-based cohort. Arterioscler Thromb Vasc Biol. 2014;34(11):2457–64.CrossRef
31.
go back to reference Lindberg S, Jensen JS, Mogelvang R, Pedersen SH, Galatius S, Flyvbjerg A, et al. Plasma neutrophil gelatinase-associated lipocalinin in the general population: association with inflammation and prognosis. Arterioscler Thromb Vasc Biol. 2014;34(9):2135–42.CrossRef Lindberg S, Jensen JS, Mogelvang R, Pedersen SH, Galatius S, Flyvbjerg A, et al. Plasma neutrophil gelatinase-associated lipocalinin in the general population: association with inflammation and prognosis. Arterioscler Thromb Vasc Biol. 2014;34(9):2135–42.CrossRef
32.
go back to reference Tarín C, Fernandez-Garcia CE, Burillo E, Pastor-Vargas C, Llamas-Granda P, Castejón B, et al. Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice. Cardiovasc Res. 2016;111(3):262–73.CrossRef Tarín C, Fernandez-Garcia CE, Burillo E, Pastor-Vargas C, Llamas-Granda P, Castejón B, et al. Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice. Cardiovasc Res. 2016;111(3):262–73.CrossRef
33.
go back to reference Song E, Fan P, Huang B, Deng HB, Cheung BM, Félétou M, et al. Deamidated lipocalin-2 induces endothelial dysfunction and hypertension in dietary obese mice. J Am Heart Assoc. 2014;3(2):e000837.CrossRef Song E, Fan P, Huang B, Deng HB, Cheung BM, Félétou M, et al. Deamidated lipocalin-2 induces endothelial dysfunction and hypertension in dietary obese mice. J Am Heart Assoc. 2014;3(2):e000837.CrossRef
34.
go back to reference Liu JT, Song E, Xu A, Berger T, Mak TW, Tse HF, et al. Lipocalin-2 deficiency prevents endothelial dysfunction associated with dietary obesity: role of cytochrome P450 2C inhibition. Br J Pharmacol. 2012;165(2):520–31.CrossRef Liu JT, Song E, Xu A, Berger T, Mak TW, Tse HF, et al. Lipocalin-2 deficiency prevents endothelial dysfunction associated with dietary obesity: role of cytochrome P450 2C inhibition. Br J Pharmacol. 2012;165(2):520–31.CrossRef
35.
go back to reference Rau S, Habicht A, Kauke T, Hillmer A, Wessely M, Stangl M, et al. Neutrophil gelatinase-associated lipocalin and end-stage renal disease: it is not all about the kidneys! Eur J Clin Investig. 2013;43(8):816–20.CrossRef Rau S, Habicht A, Kauke T, Hillmer A, Wessely M, Stangl M, et al. Neutrophil gelatinase-associated lipocalin and end-stage renal disease: it is not all about the kidneys! Eur J Clin Investig. 2013;43(8):816–20.CrossRef
36.
go back to reference Dixit M, Liu Z, Poudel SB, Yildirim G, Zhang YZ, Mehta S, et al. Skeletal response to insulin in the naturally occurring type 1 diabetes mellitus mouse model. JBMR Plus. 2021;5(5):e10483.CrossRef Dixit M, Liu Z, Poudel SB, Yildirim G, Zhang YZ, Mehta S, et al. Skeletal response to insulin in the naturally occurring type 1 diabetes mellitus mouse model. JBMR Plus. 2021;5(5):e10483.CrossRef
37.
go back to reference Donat A, Knapstein PR, Jiang S, Baranowsky A, Ballhause TM, Frosch KH, et al. Glucose metabolism in osteoblasts in healthy and pathophysiological conditions. Int J Mol Sci. 2021;22(8):4120.CrossRef Donat A, Knapstein PR, Jiang S, Baranowsky A, Ballhause TM, Frosch KH, et al. Glucose metabolism in osteoblasts in healthy and pathophysiological conditions. Int J Mol Sci. 2021;22(8):4120.CrossRef
38.
go back to reference Cipriani C, Colangelo L, Santori R, Renella M, Mastrantonio M, Minisola S, et al. The interplay between bone and glucose metabolism. Front Endocrinol (Lausanne). 2020;11:122.CrossRef Cipriani C, Colangelo L, Santori R, Renella M, Mastrantonio M, Minisola S, et al. The interplay between bone and glucose metabolism. Front Endocrinol (Lausanne). 2020;11:122.CrossRef
39.
go back to reference Moreira CA, Barreto FC, Dempster DW. New insights on diabetes and bone metabolism. J Bras Nefrol. 2015;37(4):490–5.CrossRef Moreira CA, Barreto FC, Dempster DW. New insights on diabetes and bone metabolism. J Bras Nefrol. 2015;37(4):490–5.CrossRef
40.
go back to reference Sugimoto T, Ritter C, Morrissey J, Hayes C, Slatopolsky E. Effects of high concentrations of glucose on PTH secretion in parathyroid cells. Kidney Int. 1990;37(6):1522–7.CrossRef Sugimoto T, Ritter C, Morrissey J, Hayes C, Slatopolsky E. Effects of high concentrations of glucose on PTH secretion in parathyroid cells. Kidney Int. 1990;37(6):1522–7.CrossRef
41.
go back to reference Bover J, Ureña P, Brandenburg V, Goldsmith D, Ruiz C, DaSilva I, et al. Adynamic bone disease: from bone to vessels in chronic kidney disease. Semin Nephrol. 2014;34(6):626–40.CrossRef Bover J, Ureña P, Brandenburg V, Goldsmith D, Ruiz C, DaSilva I, et al. Adynamic bone disease: from bone to vessels in chronic kidney disease. Semin Nephrol. 2014;34(6):626–40.CrossRef
Metadata
Title
Association of plasma neutrophil gelatinase-associated lipocalin and thoracic aorta calcification in maintenance hemodialysis patients with and without diabetes
Authors
Kai Wei
Gesheng Song
Linhe Xi
Juan Chen
Chuancai Sun
Ping Chen
Yong Wei
Li Wang
Xianglei Kong
Yang Li
Dongmei Xu
Xiaoyan Jia
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-022-02773-z

Other articles of this Issue 1/2022

BMC Nephrology 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.